Reaction

Dilated Cardiomyopathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 917 reports · 46 co-occurring drugs

As of the last recalculation, Dilated Cardiomyopathy appears in 917 FAERS reports alongside 46 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 68.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Eplerenone	37	68.3	68.5
Theophylline	19	38.3	38.4
Bleomycin Sulfate	17	38.0	38.1
Dapagliflozin	48	36.5	36.5
Theophylline Anhydrous	19	35.5	35.6
Pertuzumab	34	29.4	29.5
Leucovorin Calcium	21	25.5	25.5
Doxorubicin Hydrochloride	34	24.5	24.5
Botulinum Toxin Type A	12	22.2	22.2
Amphetamine	8	22.1	22.2
Doxorubicin	79	21.9	21.9
Ado-Trastuzumab Emtansine	8	21.7	21.7
Torsemide	29	20.5	20.5
Bumetanide	21	18.4	18.5
Norepinephrine	8	17.1	17.1
Trastuzumab	49	17.1	17.1
Panitumumab	11	16.1	16.1
Paclitaxel (Aibumin-Bound)	55	16.1	16.1
Valacyclovir	28	15.7	15.7
Azacitidine For	12	15.2	15.2
Norepinephrine Bitartrate	9	14.3	14.3
Paclitaxel	55	13.3	13.4
Cyclophosphamide Injection, Solution	93	13.2	13.2
Cyclophosphamide	93	13.2	13.2
Cyclophosphamide For Injection	93	13.2	13.2
Testosterone Cypionate	5	12.8	12.8
Docetaxel Anhydrous	35	12.2	12.2
Docetaxel	35	12.2	12.2
Sacubitril And Valsartan	57	11.8	11.8
Imatinib	9	11.7	11.7
Oxaliplatin	33	10.4	10.4
Azacitidine	13	10.1	10.1
Capecitabine	38	9.8	9.8
Ifosfamide	9	9.6	9.6
Daratumumab	16	9.2	9.2
Romiplostim	6	9.1	9.1
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	4	9.1	9.1
Fam-Trastuzumab Deruxtecan-Nxki	4	9.0	9.0
Irinotecan Hydrochloride	5	8.9	8.9
Blinatumomab	4	8.7	8.7
Carfilzomib	10	8.1	8.1
Apalutamide	4	7.8	7.8
Paliperidone Palmitate	9	6.4	6.4
Velpatasvir And Sofosbuvir	3	5.3	5.3
Osimertinib	7	5.0	5.0
Guselkumab	6	3.8	3.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.